Amid the resurgence in Covid cases, China's indigenous vaccines, "CanSino" and "BBIBPCorV," were heavily scrutinized based on their efficacy rates. There were concerns about the legitimacy of these vaccines raised concerns after certain documents were leaked online, labeled "extra urgent and
Before World Cancer Day (4 February), a new study from the University of Southampton's Centre for Cancer Immunology demonstrated that altering how tightly an antibody attaches to a target could enhance cancer therapies.
Researchers at UCSF have developed a novel, potentially life-saving approach that may prevent antibodies from triggering immune rejection of engineered therapeutic and transplant cells.
The most recent study clarifies how Pfizer and Moderna mRNA boosters influence the persistence of our Covid-19 antibodies. According to the researchers, a booster produced more durable antibodies in all individuals, including those who had recovered from a Covid-19 infection.
Patients with Antiphospholipid syndrome (APS0, an autoimmune disease that preferentially affects women, are typically given different medications to reduce their risk of blood clotting and help normalize lab values such as platelet count. Despite this, patients sometimes internally feel that
New research from the University of Virginia School of Medicine speaks to the benefits of a Covid-19 booster. The new findings shed light on how mRNA boosters - both Pfizer and Moderna - affect the durability of our antibodies to Covid-19. A booster, the researchers report, made for longer-l
The microscopic biological structures known as germinal centres are the immune system's weapons-development facilities if B cells are the immune system's munitions manufacturers, producing antibodies to eliminate hazardous infections.
People with blood cancer usually have a weak immune system, putting them at an increased risk of becoming very ill from COVID-19. Furthermore, several cancer treatments cause these individuals to develop little or no antibodies against SARS-CoV-2 after COVID-19 vaccination.
Viruses such as SARS-CoV-2, influenza virus and others travel from person to person essentially by hitchhiking on aerosols. These are finely dispersed particles containing liquid suspended in the air that an infected person expels when coughing, sneezing, or simply exhaling, and can be inhal
Researchers at Michigan Medicine have developed a new biomarker-based technique to screen for a rare and fatal consequence caused by monoclonal antibodies, which are used to treat a variety of tumours.
Nearly three years into the pandemic, many of us now carry antibodies against the virus--due to an infection or two, a few doses of mRNA vaccine, or a round of monoclonal-antibody treatment. But not all immune responses are created equal, and how we first developed our antibodies may influen
Rapid, low-cost, and accurate tests are still required for epidemiological surveillance and healthcare services to monitor and contain the spread of SARS-CoV-2. Brazilian researchers have contributed to this field's efforts by creating an electrochemical immunosensor that identifies antibodi